Tovinontrine, Tovinontrine, Tovinontrine, tovinontrine-matching placebo, immediate-release tablet
CRD-750-201
Phase 2 small_molecule active
Quick answer
Tovinontrine, Tovinontrine, Tovinontrine, tovinontrine-matching placebo, immediate-release tablet for Heart failure (HF) with reduced ejection fraction (HFrEF) is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Heart failure (HF) with reduced ejection fraction (HFrEF)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active